Bill Sponsor
House Bill 19
116th Congress(2019-2020)
Lower Costs, More Cures Act of 2019
Introduced
Introduced
Introduced in House on Dec 9, 2019
Overview
Text
Introduced
Dec 9, 2019
Latest Action
Dec 19, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
19
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Oregon
Republican
Alabama
Republican
Arkansas
Republican
Arkansas
Republican
California
Republican
California
Republican
California
Republican
Florida
Republican
Florida
Republican
Georgia
Republican
Illinois
Republican
Illinois
Republican
Illinois
Republican
Illinois
Republican
Indiana
Republican
Indiana
Republican
Indiana
Republican
Kansas
Republican
Kentucky
Republican
Kentucky
Republican
Kentucky
Republican
Louisiana
Republican
Louisiana
Republican
Louisiana
Republican
Maryland
Republican
Michigan
Republican
Michigan
Republican
Michigan
Republican
Minnesota
Republican
Minnesota
Republican
Mississippi
Republican
Missouri
Republican
Missouri
Republican
Missouri
Republican
Nebraska
Republican
Nebraska
Republican
New Jersey
Republican
New York
Republican
New York
Republican
New York
Republican
New York
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Dakota
Republican
Oklahoma
Republican
Oklahoma
Republican
Pennsylvania
Republican
Pennsylvania
Republican
Pennsylvania
Republican
Pennsylvania
Republican
Pennsylvania
Republican
Pennsylvania
Republican
Pennsylvania
Republican
Pennsylvania
Republican
South Carolina
Republican
South Carolina
Republican
South Carolina
Republican
South Carolina
Republican
South Carolina
Republican
South Dakota
Republican
Tennessee
Republican
Tennessee
Republican
Tennessee
Republican
Tennessee
Republican
Virginia
Republican
Washington
Republican
West Virginia
Republican
West Virginia
Republican
West Virginia
Republican
Wisconsin
Republican
Wyoming
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit,
  • modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
  • revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.
Text (1)
December 9, 2019
Actions (4)
12/19/2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
12/10/2019
Referred to the Subcommittee on Health.
12/09/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
12/09/2019
Introduced in House
Public Record
Record Updated
Oct 28, 2022 1:46:01 AM